Sofia-based Blue Longevity Clinic secured €2 million in a recent funding round. Eleven Ventures led the investment, with participation from Sofia Angels Ventures and several family offices. This capital will support the HealthTech provider's expansion.
The funding enables Blue Longevity Clinic to launch new clinics in Greece, Turkey, and Bulgaria. The company offers integrated longevity medicine services, combining in-person functional diagnostics with personalized therapy modules. A proprietary digital app also supports patient healthy lifestyle choices.
Blue Longevity Clinic focuses on extending healthspan, moving beyond traditional sick care. This approach identifies early deviations from optimal function.
Advancing Longevity Medicine in Europe
New clinics are set to open in Athens, Istanbul, and Sofia by September. The company will further develop its digital health app and AI diagnostics engine. This expansion aims to democratize longevity medicine, previously limited to high-net-worth individuals, to the emerging upper-middle class in the region.
The transition to preventive healthcare marks a global shift. Blue Longevity Clinic aims to become a regional leader in longevity medicine, differentiating from diagnostic-only or non-personalized models. Other players in the broader longevity space include companies like Forward Health and Human Longevity Inc..
